Company Filing History:
3 out of 10 
2 out of 49 
2 out of 25 
Years Active: 2018-2025
Title: Masayoshi Toyoura: Innovator in Anti-PAD4 Antibodies
Introduction
Masayoshi Toyoura is a prominent inventor based in Kyoto, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of anti-PAD4 antibodies. With a total of 5 patents to his name, Toyoura's work is paving the way for innovative treatments in rheumatoid arthritis (RA).
Latest Patents
Toyoura's latest patents focus on anti-PAD4 antibodies that exhibit excellent properties for the treatment of RA. These antibodies specifically bind to an epitope containing positions 345, 347, and 348 of PAD4. They are designed to inhibit the citrullination activity of PAD4, which is crucial in the pathology of RA. Additionally, these anti-PAD4 antibodies may have a KD (M) of 9.0×10 or less. In some cases, the anti-PAD4 antibody is used in combination with a TNFα inhibitor to enhance therapeutic efficacy.
Career Highlights
Throughout his career, Masayoshi Toyoura has worked with notable organizations such as Pharma Foods International Co., Ltd. and Kochi University. His research and innovations have significantly impacted the field of immunology and therapeutic development.
Collaborations
Some of Toyoura's key collaborators include Yuji Shoya and Chihiro Yamazaki. Their combined expertise has contributed to the advancement of research in antibody development.
Conclusion
Masayoshi Toyoura's innovative work in the field of anti-PAD4 antibodies represents a significant advancement in the treatment of rheumatoid arthritis. His contributions continue to inspire future research and development in biotechnology.